Our mission is to facilitate the development of optometry around the world and support optometrists in promoting eye health and vision care as a human right through advocacy, education, policy development and humanitarian outreach.

Learn More 》


The World Council of Optometry periodically hosts webinars regarding current topics in optometry today. Please check back for new videos and information as they become available.

WCO Global Education Event

Eyes Around the World – A Global Day of Learning 

November 20, 2021

The World Council of Optometry hosted Eyes Around the World – A Global Day of Learning on November 20, 2021. The conference program encompassed 3 time zones over 24 hours and included speakers from 12 countries with presentations aimed at both practicing clinicians and optometric educators.

Click here to view all of the lectures from this event.


WCO would like to thank the Association of Schools and Colleges of Optometry (ASCO), CooperVision, and the International Association of Contact Lens Educators (IACLE) for supporting this event.


WCO Dry Eye Webinar

Dry Eye: The New Frontier 

June 16, 2021 6:00am-7:30am CDT

Please enjoy the World Council of Optometry’s latest webinar, “Dry Eye: The New Frontier,” presented by WCO and supported by Alcon. We are thrilled to have had five experts from around the globe weigh in on our panel for this event.

We would also like to thank Mr. Jonathon Bench, representing Alcon, for joining us.

WCO Dry Eye Webinar


Therapeutic research optometrist, Jennifer P. Craig is a Professor of Ophthalmology at the University of Auckland in New Zealand, where she heads the Ocular Surface Laboratory and leads international multicenter clinical trials. Since being awarded her PhD on the tear film in the normal and dry eye disease, Jennifer has maintained her research interest in the ocular surface and the tear film, with a focus on evaporative dry eye disease and meibomian gland dysfunction. She regularly delivers continuing education and research lectures internationally (virtually, if not in person), and publishes widely in both the scientific and clinical press. She is a TFOS Director and Ambassador and has contributed to the Tear Film and Ocular Surface Society’s International Workshops on Meibomian Gland Dysfunction, on Contact Lens Discomfort. She served as Vice-Chair of TFOS DEWS II, and is leading the upcoming TFOS International Workshop on A Lifestyle Epidemic: Ocular Surface Disease, as Chair. Jennifer holds visiting academic appointments at Aston University in the UK, the Universities of Waterloo and Montreal in Canada, and is a Visiting Professor at the University of Medical Sciences in Wenzhou, China.

Following a 1st class Optometry degree from Manchester, a pre-registration year at Moorfield’s Eye Hospital, London, a PhD at Cardiff University and a clinical/research fellowship at the University of Melbourne, Australia, Professor Wolffsohn was appointed by Aston University in 2000, where he was Head of Optometry 2004-9 and Deputy Executive Dean for Life and Health Sciences 2009-16, being awarded a personal Chair in 2007. He is now associate Pro-Vice Chancellor. James has published over 265 peer reviewed academic papers and given numerous international presentations. His main research areas are the development and evaluation of ophthalmic instrumentation, contact lenses, intraocular lenses, and the tear film. He is the academic Chair of the British Contact Lens Association, having been a past president, was a harmonizer and sub-committee chair for TFOS DEWS II and joint-Chair of the International Myopia Institute reports, and was chair of the BCLA Contact Lens Evidence-based Academic Reports (CLEAR).

Caroline Blackie currently serves as a Senior Medical Director at Johnson and Johnson Vision (JJV). Caroline joined Johnson and Johnson Vision after 12 years with TearScience where she worked in clinical development and led the medical affairs function to support the launch of the entire TearScience portfolio. Along this journey, Caroline became an internationally recognized clinical and scientific expert in the field of dry eye with specific focus on meibomian gland dysfunction. Passionate about the patient experience, she has also accrued approximately 20 years of direct patient care experience in her career. Her years in direct clinical care fuel her desire to elevate and transform the standard of care towards a more proactive approach to the health of the ocular surface.

Dr. Senol Demircan currently serves as the International Therapeutic Area Director (Medical Affairs) supporting the Vision Care and Ocular Health Franchise at Alcon. Within this role, Senol focuses on guiding clinical data generation efforts around Dry Eye Disease and solutions provided by Alcon, within international markets. He has both led and co-led many award winning projects within Alcon, purely focusing on the endpoint of helping patients to see better. Senol obtained his Medical Doctorate degree from the Hacettepe University Faculty of Medicine in Ankara, Turkey. Currently residing in Switzerland, he is also an avid artificial intelligence and block chain enthusiast.

Dr. Richard Maharaj is the current medical director for eyeLABS Center for Ocular Surface Disease a leading specialty eye care and research facility in Brampton, Ontario. He obtained his Doctor of Optometry from the University of Waterloo School of Optometry and is an active Fellow of the American Academy of Optometry. He is a clinical adjunct faculty for the University of Waterloo School of Optometry, the Canadian Association of Optometrists Section Chair for Ocular Surface Disease, Editorial Board Member for The Journal of Dry Eye and Ocular Surface Disease, and Chief Education Officer at MyDryEye.ca and co-founder for the Canadian Dry Eye Summit – a national conference dedicated to educating eye doctors in the area of dry eye disease management. In 2018, he was honored as one of the Top 40 Canadian Optometrists under 40 by Johnson and Johnson Vision Care. As a published international speaker and clinical scientist on diseases of the ocular surface and the psychology of health care, he remains an active member of both national and international professional associations.


The World Council of Optometry thanks Alcon for their generous support of this webinar.


WCO World Glaucoma Week Webinar

How Do We Work Towards Collaborative Care?

March 10, 2021 6:00am-6:45am CST

Can optometry and ophthalmology work together to bring patient centered care to the forefront of glaucoma treatment? Watch the World Council of Optometry webinar panelists discuss this topic.

WCO thanks ECOO for hosting our webinar.

WCO World Glaucoma Week Webinar


Dr. Semby is a Senior Consultant in Ophthalmology at the Department of Ophthalmology, Linköping University Hospital. Furthermore, he is an Affiliated Researcher since April 2017 at the Department of Clinical Neuroscience, Karolinska Institute, Stockholm. Additionally, he was Head of Department of Glaucoma in Halland County, Sweden. Since 2018, he has been a Project Manager/Organizer for glaucoma research, and has a clinical practice mainly focused on glaucoma since January 2019.

Over the 26 years since graduating from Queensland University of Technology with a Bachelor of Applied Science (Optometry), Melinda’s career has been varied, practicing in the public sector, private practice, university clinics and in corporate settings, in roles ranging from clinical, managerial to educator. During this time Melinda developed a special interest in ocular diseases, ocular therapeutics, evidence-based practice and public health optometry. Melinda has also gained the following qualifications: post-graduate Master of Optometry, Master of Business Administration, Graduate Certificate of Ocular Therapeutics and Certificate of Public Health and Eyecare Leadership. Melinda is currently a PhD candidate investigating the quality and safety of glaucoma care delivery by Australian optometrists. Melinda has been an OQNT board director since 2015 and was President from 2017 – 2020.

Glaucoma Webinar Takeaway Sheet

Glaucoma Webinar Takeaway


Download here.

WCO Myopia Management Webinar

January 27, 2021 8:00am-9:30am CST

The World Council of Optometry (WCO) presents the Myopia Management Webinar. Myopia has gained increased prominence as part of the global public health agenda, and given the plethora of information on myopia, WCO hosts a panel discussion with key experts. These experts will help us navigate the complex field of myopia and myopia management.

We thank our panelists and Dr. Gary Orsborn representing CooperVision and Ms. Olga Prenat representing Essilor for joining us.

WCO Myopia Management Webinar


Ian Flitcroft is a consultant pediatric ophthalmologist at the Children’s University Hospital, Dublin. He is also Associate Clinical Professor of Ophthalmology in UCD and Adjunct Professor of Vision Science at the Technological University Dublin.  He has been involved in the field of experimental myopia for 25 years. As well as his research on the mechanisms guiding eye growth, he has been long term advocate for the public health implications of myopia and for the need for biological treatments of myopia. He is a lead investigator on several myopia treatment trials.

Indie is a qualified Dispensing Optician and Optometrist with 30 years experience within the Optical Industry. Shortly after qualifying as an Optometrist he joined Visioncare Research as a Research Optometrist. He opened his own Leightons Franchise in St Albans in 2001, as well as participating in contact lens clinical trials, he has a special interest in Myopia Management and Multifocal contact lens fitting. Indie’s passion for contact lenses has seen him work with major contact lens manufacturers and as a key opinion leader he has presented both in the UK and internationally. Indie is a BCLA Fellow and holds a diploma in Independent Prescribing.

Monica is the Executive Director of the International Myopia Institute (IMI), the global expert body focused on advancing myopia research, education and management to prevent future vision impairment and blindness from high myopia related complications.  Her research interests include refractive error, understanding myopia risk factors, myopia control, and the public health impacts. Monica has co-supervised graduate students, authored peer reviewed articles, and the WHO report on “The Impact of myopia and high myopia.”  She also co-created the BHVI global online myopia management education program and speaks regularly at key international meetings.

Dr. Liu is an Associate Professor of Clinical Optometry at UC Berkeley. The emphasis of her research and clinical expertise is the investigation and utilization of novel contact-lens designs and pharmaceuticals in myopia control. She is the founder and chief of the Myopia Control Clinic, the first of its kind in a teaching clinic; it now serves as a model for optometry schools across the country. Originally from Beijing, Liu practiced as an ophthalmologist in China before relocating to the US in 2000. She obtained her MBA prior to her OD training at Pacific University, College of Optometry. She also completed an MPH and a PhD at UC Berkeley.

Matt Oerding is a global business executive with over 20 years of leadership experience with Novartis, General Mills and General Electric. He has held leadership roles in marketing, strategy and general management in the U.S., Europe and Asia.

Passionate about making a difference in people’s lives, Matt focused his career on the health care sector, joining Novartis’ eye care division in 2001. Over the last 20 years, Matt has launched new contact lens products globally, led R&D pipeline efforts for new eye care devices, and been a country general manager running over $100 million businesses with full P&L accountability. In 2015 Matt co-founded Treehouse Eyes, a retail eye care business focused on new models to treat myopia in children. Matt is the CEO of Treehouse Eyes, which now has 23 locations in 11 states across the United States focused on treating myopic children. Matt is also the Board Chair for the Global Myopia Awareness Coalition (GMAC), a coalition of 15 companies and associates in eye care focused on driving public awareness of childhood myopia and treatment options.


Matt lives in Boulder, Colorado with his wife and 2 daughters.

Fuensanta Vera-Diaz received a PhD in Optometry from the University of Bradford, UK, for her work investigating optical and neural influences on visual performance in myopia. She then undertook a postdoctoral research position at the New England College of Optometry (NECO) to investigate oculomotor factors that may predict phenotypes at risk for myopia. As a research fellow at Schepens Eye Research Institute at Harvard Medical School, she conducted studies that have significant implications on the prescription of optical devices and vision enhancement aids for patients with visual impairment. Dr. Vera-Diaz is currently tenured Associated Professor at NECO.


Dr. Vera-Diaz has developed a successful research program at NECO, funded by the NIH. She investigates mechanisms contributing to the development of myopia, specifically, optical, retinal and visual processing structures and functions of the human visual system. She also leads the Myopia Control Clinic at NECO.


Dr. Vera-Diaz has a strong publication record, with many peer-reviewed publications in high-quality peer-reviewed journals related to myopia and several book chapters. This is a link to her up-to-date list of her NCBI publications. She serves as a reviewer for multiple vision science journals, including IOVS, and is a reviewer in NIH special emphasis study panel sections.


The World Council of Optometry thanks CooperVision and Essilor for their generous support of this webinar.